CCL2 Recombinant Monoclonal Antibody
The CCL2 Recombinant Monoclonal Antibody is applicable for the following applications: ELISA, IHC. Host: Human. Species Reactivity: Human (Homo sapiens) . Immunogen: Recombinant Human CCL2 protein. Accession Number: P13500. Target Synonyms: C-C motif chemokine 2; CCL2; CCL2_HUMAN; Chemokine (C C motif) ligand 2; GDCF 2; GDCF-2; GDCF2; HC11; HSMCR30; JE; MCAF; MCP 1; MCP-1; MCP1; MGC9434; Monocyte chemoattractant protein 1; Monocyte chemotactic and activating factor; Monocyte chemotactic protein 1; Monocyte secretory protein JE; SCYA2; Small inducible cytokine A2 (monocyte chemotactic protein 1; homologous to mouse Sig je) ; Small inducible cytokine A2; Small inducible cytokine subfamily A (Cys Cys) ; member 2; Small-inducible cytokine A2; SMC CF; SMC-CF; SMCCF. Restrictions: For Research Use Only. Not for use in diagnostic procedures.
Product Specifications
Short Description
The CCL2 Recombinant Monoclonal Antibody is applicable for the following applications: ELISA, IHC.
Accession Number
P13500
Host
Human
Reactivity
Human (Homo sapiens)
Immunogen
Recombinant Human CCL2 protein
Target
CCL2
Clonality
Recombinant Monoclonal
Clone
5F8
Conjugation
Unconjugated. Conjugated antibodies are available (Biotin, FITC and HRP), please inquire.
Applications
ELISA, IHC
Field of Research
Cancer, Cardiovascular, Immunology, Metabolism
Purification
Affinity-chromatography
Concentration
Lot specific. Please inquire or refer to the datasheet included in the product pouch.
Format
Liquid
Buffer
0.03% Proclin 300, 50% glycerol, 0.01M PBS, pH 7.4
Shipping Conditions
Ice packs
Storage Conditions
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Fragment
IgG1
Target Alternative Name
Species
Human (Homo sapiens)
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
EXOC3 (Exocyst Complex Component 3, SEC6, SEC6L1, Sec6p) (MaxLight 550)
EXOC3 (Exocyst Complex Component 3, SEC6, SEC6L1, Sec6p) (MaxLight 550)
